Joachim Ehrlich (JW Goethe University, Frankfurt) talks about the second-generation balloons used in single-shot cryoablation techniques and their efficacy over older technologies in atrial fibrillation. He also discusses the advantages of cryoablation over radiofrequency ablation; although, as the FIRE AND ICE trial showed, efficacy is similar between both techniques, cryoablation is easier to use and quicker in treating patients with paroxysmal atrial fibrillation. With the new-generation cryoballoon catheter, the speed of the procedure overall is quicker and success can be monitored online. Dr Ehrlich predicts that, due to the simplicity and ease of the cryoablation procedure, many physicians will be able to treat their patients with this technique.
Filmed at EHRA 2018, Barcelona.
1. Please can you describe any recent progress that has been made in single-shot cryoablation techniques? 0:07
2. What are the advantages of cryoablation over radiofrequency ablation and how do they differ in terms of efficacy? 0:36
3. How do the features of the new-generation cryoballoon catheter contribute to its ease of use? 1:07
4. What are the clinical implications of cryoablation and what is the impact on patient outcomes in the real world? 1:34
Share this Video
Related Videos In Atrial Fibrillation
Anthony Tang, ACC 2021: Findings from the RAFT-AF Trial
It was a great pleasure to meet with Anthony Tang to discuss the RAFT-AF trial results investigating the safety and efficacy of catheter ablation-based rhythm control compared with rate control for the treatment of patients with atrial fibrillation and heart failure, presented at ACC 2021. Abstract Title: A Randomized Ablation-based atrial Fibrillation rhythm control versus […]
Michiel Rienstra and Bao-Oanh Nguyen, EHRA 2021 – Long-term Outcomes of the RACE 3 Trial
Professor Michiel Rienstra and Dr Bao-Oanh Nguyen (University Medical Center Groningen, Groningen, The Netherlands) gave us an overview of the RACE-3 study (NCT00877643) from the European Heart Rhythm Association (EHRA) Virtual Meeting 2021. Questions: What is the rationale for targeted therapy of underlying conditions in patients with persistent atrial fibrillation (AF) and mild to moderate […]
Faizel Osman, A-A Heart Rhythm Updates 2021: 2020 ESC AF Guidelines
We spoke to Professor Faizel Osman (Consultant Cardiologist and Electrophysiologist, University Hospital Coventry and Warwickshire NHS Trust, Coventry, UK) who gave us an update about the recent new ESC Guidelines for Atrial Fibrillation and the upcoming Arrhythmia Alliance Heart Rhythm Updates 2021. Questions What are the most important new recommendations in the 2020 ESC atrial […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!